Anti-Human CD3xCD20 (Synonyms: Glofitamab; RO7082859; )

Size	Availability	Price(USD)	VIP Price (USD)	Quantity
1 mg	3-5days	$1100.00	Visible after login	- +
5 mg	3-5days	$1600.00	Visible after login	- +

Product Overview

Product Name	Anti-Human CD3xCD20 (Synonyms: Glofitamab; RO7082859; CD20-TCB ,RG-6026;CD3e, CD3 epsilon;membrane-spanning 4-domains subfamily A member 1, CD20,MS4A1)
CAS	2229047-91-8
Appearance	Colorless to light yellow liquid
Storage condition	store at -20°C

Security information

Product details

Glofitamab is a T-cell-engaging bispecific antibody possessing a novel 2:1 structure with bivalency for CD20 on B cells and monovalency for CD3 on T cells. Glofitamab is used as an effective therapy for relapsed or refractory diffuse large B-cell lymphoma.

Related literature

Pharmacodynamics and molecular correlates of response to glofitamab in relapsed/refractory non-Hodgkin lymphoma.

PMID: 34941996 PMCID: PMC8945294 DOI: 10.1182/bloodadvances.2021005954

PMID: 33739857 PMCID: PMC8210975 DOI: 10.1200/JCO.20.03175

PMID: 34953862 DOI: 10.1016/j.xphs.2021.12.019

PMID: 33406104 PMCID: PMC7787458 DOI: 10.1371/journal.pone.0241091

History

CLA1659

Anti-Human CD3xCD20 (Synonyms: Glofitamab; RO7082859; CD20-TCB ,RG-6026;CD3e, CD3 epsilon;membrane-spanning 4-domains subfamily A member 1, CD20,MS4A1)

Anti-Human CD3xCD20 (Synonyms: Glofitamab; RO7082859; CD20-TCB ,RG-6026;CD3e, CD3 epsilon;membrane-spanning 4-domains subfamily A member 1, CD20,MS4A1)

Chemical safety data sheet(MSDS)